Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK by Damery, Sarah et al.
 
 
University of Birmingham
Colorectal cancer screening using the faecal occult
blood test (FOBt): a survey of GP attitudes and
practices in the UK
Damery, Sarah; Clifford, Susan; Wilson, Sue
DOI:
10.1186/1471-2296-11-20
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Damery, S, Clifford, S & Wilson, S 2010, 'Colorectal cancer screening using the faecal occult blood test (FOBt):
a survey of GP attitudes and practices in the UK', BMC Family Practice, vol. 11, 20.
https://doi.org/10.1186/1471-2296-11-20
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.
Checked July 2015
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
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Colorectal cancer screening using the faecal
occult blood test (FOBt): a survey of GP attitudes
and practices in the UK
Sarah Damery*, Sue Clifford, Sue Wilson
Abstract
Background: Colorectal cancer (CRC) is the third most common cancer in the UK. Five-year survival rates are less
than 50%, largely because of late diagnosis. Screening using faecal occult blood tests (FOBt) can detect bowel
cancer at an earlier stage than symptomatic presentation, and has the potential to significantly decrease colorectal
cancer mortality. However, uptake of screening is currently low, despite the introduction of the NHS Bowel Cancer
Screening Programme (NHSBCSP), and it has been suggested that GP recommendations of screening can improve
patient compliance. GP recommendation of CRC screening is argued to be affected by attitudes towards it, along
with perceptions of its efficacy.
Methods: This paper presents the findings of a cross-sectional postal survey of GPs in the UK which aimed to
investigate GPs’ attitudes in relation to colorectal cancer screening and the use of FOBt in routine practice. An
‘attitude’ score was calculated, and binary logistic regression used to evaluate the association of socio-demographic
and general practice attributes with attitudes towards CRC screening and FOBt.
Results: Of 3,191 GPs surveyed, 960 returned usable responses (response rate 30.7%). Positive attitudes were
associated with personal experience of CRC screening and Asian or Asian British ethnicity. GPs from practices
located in more deprived locations were also more likely to have positive attitudes towards FOBt and its
recommendation to patients.
Conclusions: The success of population-based screening for CRC will largely be determined by GP attitudes and
support, particularly with regard to FOBt. Previous research has implied that South Asian GPs are more likely to
have negative attitudes towards FOBt screening, however, our research suggests that this is not a group requiring
targeted interventions to increase their support for the NHSBCSP. Of the available CRC screening tests, GPs
perceived FOBt to be the most appropriate for population-based screening.
Background
Colorectal cancer (CRC) is the third most common can-
cer, and the second leading cause of cancer death in the
UK, with 35,000 diagnoses and 16,000 deaths per year
[1]. It incurs an annual National Health Service (NHS)
expenditure of more than £300 million in surgical, adju-
vant and palliative treatment [2]. Despite this, the five-
year CRC survival rate is currently only 48% [3]; lower
than in other European countries [4,5]. This poor survival
rate is largely attributable to late diagnosis; therefore an
effective means of improving CRC survival and reducing
the burden of the disease to the NHS is to facilitate early
diagnosis and treatment through CRC screening [1].
Biennial bowel cancer screening using the faecal occult
blood test (FOBt) has been shown to have the potential
to reduce mortality from bowel cancer by 16% [6]. FOBt
screening in the asymptomatic average-risk population
can detect bowel cancer at an earlier stage than would be
the case through symptomatic presentation, increasing
the potential effectiveness of treatment [7]. It also allows
the identification of precursors to invasive disease which
can be removed subsequently during colonoscopy to les-
sen the likelihood of CRC developing. In addition to
improved survival, earlier diagnosis through CRC
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screening can contribute to improved quality of life and
reduced NHS treatment costs [8]. However, if the poten-
tial morbidity and mortality benefits are to be realised,
high levels of screening uptake and the continued adher-
ence to regular screening must be achieved and main-
tained in the eligible population.
The NHS Bowel Cancer Screening Programme
(NHSBCSP) was introduced in England in 2006 [9]. The
programme aims to screen men and women aged
between 60 and 74 years for CRC every two years using
FOBt, and it is estimated that there would be 20,000
fewer deaths from CRC over the next 20 years if screen-
ing had an uptake of 60% [10]. However, current uptake
is 52% [11], a rate which appears to be falling in rounds
subsequent to the prevalent round [12]. Uptake is consid-
erably lower than this in some population sub-groups,
with men, those in younger age groups, those from the
Indian sub-continent and people living in deprived areas
least likely to participate [11,13]. Whilst General Practi-
tioners (GPs) in the UK are not directly involved in
administering bowel cancer screening, the national pilot
study for the NHSBCSP demonstrated that GP attitudes
to screening appear to be an important determinant of
uptake [14]. GP involvement has been shown to improve
compliance with CRC screening in general [15-17], and
to increase uptake of FOBt in particular [18,19]. If the
potential benefits of bowel cancer screening are to be
realised, GPs must be actively engaged [20].
Studies undertaken internationally suggest that the
beliefs and practices of GPs in relation to CRC screen-
ing and FOBt vary widely. The recommendation of CRC
screening has been found to be associated with GP per-
ceptions of screening and test efficacy [21]; the existence
of guidelines underpinning clinical practice [22], and
training [23]. Socio-demographic factors such as GP age,
gender and ethnicity have been found to have mixed
influences [14,23,24], as have GP practice attributes
such as practice size, number of registered patients and
practice location [22,24]. However, much of this existing
research has focused on opportunistic rather than popu-
lation-based screening [15], and due to differences in
national healthcare systems and in the relative involve-
ment of primary care in delivering CRC screening, stu-
dies undertaken outside of the UK may have limited
applicability to the UK context.
This paper presents the findings of a cross-sectional
postal survey of GPs in the UK which aimed to investi-
gate GPs’ attitudes in relation to colorectal cancer
screening and the use of FOBt in routine practice.
Methods
Participants
A random sample of GPs (n = 31,358) was selected using
the MidReC database (derived from the Prescription
Pricing Division Database for England). The sample was
stratified by practice size, and, by linking practice post-
code to the Index of Multiple Deprivation (IMD) 2004
[25], by deprivation quartile. The IMD 2004 is a weighted
area level aggregation of a number of ‘domains’ of depri-
vation (income, employment, health inequality, disability,
education, skills and training, barriers to housing ser-
vices, crime and the living environment). Lower IMD
scores indicate more deprived areas, whereas higher
scores are associated with less deprived locations. A
‘small’ practice was defined as one having three GPs or
fewer (n = 7,987; 25.9%), and ‘multiple’ as having four
GPs or more (n = 22,874; 74.1%). ‘Affluent’ practices
were defined as those with an IMD 2004 rank of 16242
or higher (n = 17,654; 57.2%), and ‘deprived’ practices
as those with an IMD 2004 rank of 16241 or lower
(n = 13,207; 42.8%). Those with no IMD rank were
excluded (n = 497; 1.6%). Combining these factors, all
practices in the sample were stratified according to prac-
tice size and IMD quartile, and each was allocated to one
of four groups: small/affluent (n = 5,295; 16.9%), small/
deprived (n = 2,692; 8.6%), multiple/affluent (n = 12,359;
39.4%), or multiple/deprived (n = 10,515; 33.5%). 800
GPs were randomly selected from each of these four
groups.
After excluding nine GPs who had recently been con-
tacted as part of a medical student project on attitudes
to CRC screening, self-completion surveys were sent to
a total of 3,191 GPs between August and October 2007.
This mailing assumed a conservative 40% response rate,
to yield a sample size sufficient to determine the overall
proportion of respondents with negative attitudes
towards, and resistance to, FOBt based screening with
5% precision (95% confidence), based on a worst case
scenario of 50% reporting such attitudes. Recipients
wishing to participate were able to return the survey
directly to the research team using an enclosed Freepost
envelope. Non-respondents received one reminder. No
incentive was offered for survey completion. Mailing
was undertaken in October and November 2007, during
the period where the National Bowel Screening Pro-
gramme was being rolled out.
Survey
The survey (Additional file 1) was a modified version of
a postal questionnaire designed by the US National Can-
cer Institute (NCI) colorectal cancer screening team
[26]. Prior to mailing, the modified survey was piloted
using a sample of GPs within the Department of Pri-
mary Care, University of Birmingham to test ease of
completion and to ensure comprehensibility. The survey
included closed questions with categorical and Likert
scale response options. Questions focused on the per-
ceived effectiveness of cancer screening in general, and
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colorectal cancer screening in particular; factors influen-
cing GP recommendation of CRC screening; perceived
patient and system-related barriers to CRC screening,
and current practice in relation to screening using FOBt
for asymptomatic average-risk patients. Further ques-
tions gained information on socio-demographic charac-
teristics of respondents (ethnicity, personal experience
of CRC screening, affiliation with medical school) and
GP practice attributes (practice setting, number of part-
ners, list size, age profile of registered patients).
Data analysis
Analysis focused on the socio-demographic characteris-
tics and general practice attributes of respondents, and
their relationship with stated attitudes towards the
recommendation or otherwise of FOBt. A score was cal-
culated based on the responses to three survey questions
to represent a proxy measure of GP attitudes to FOBt
screening (Table 1). Possible attitude scores ranged from
a minimum of three to a maximum of nine. Responses
were dichotomised between those with an attitude score
of seven and above (representing a positive attitude),
and those scoring six or lower (negative attitude). Binary
logistic regression was used to calculate bivariate Odds
Ratios to evaluate the association of socio-demographic
and practice attributes with attitudes towards FOBt.
Data were analysed using parametric or non-parametric
tests for comparison of means and proportions as
appropriate. This included analysis of differences
between survey responders and non-responders where
data on the relevant characteristics for non-responders
(practice size, deprivation quartile, and ethnicity) could
be obtained from the MidReC database. All data were
analysed using SPSS (version 14.0).
Ethical approval
NHS ethical and Trust approvals were secured from
Suffolk Local Research Ethics Committee (25th May
2007; Ref: 07/Q0102/45), and Birmingham and Solihull
PCT Consortium (Ref: 1087).
Results
Of 3,191 surveys distributed, 68 (2.1%) were returned as
‘undeliverable’, and 315 (9.9%) were returned blank,
indicating a desire not to receive a reminder. A further
1,849 recipients (57.9%) did not respond to either the
initial mailing or the reminder, giving a total of 960
usable responses (response rate 30.7%), see Figure 1.
Some statistically significant differences between the
GP practice characteristics of responders and non-
responders were found. GPs in practices located in less
deprived areas were more likely to respond; those from
more deprived areas were under-represented (X2 = 10.3;
p = 0.016). Similarly, those from practices with larger
numbers of GPs were significantly more likely
to respond than those in single-handed practices
(X2 = 16.2; p = 0.003), and GPs working in practices
with a greater proportion of patients in the white British
ethnic group were over-represented in survey responses
received (X2 = 14.1; p = 0.007). However, when practices
were aggregated by stratification factors (e.g. small/
deprived, large/affluent), no statistically significant dif-
ferences in response rates were observed between the
groups (Table 2).
Characteristics of respondents
The majority of survey respondents were White British
(n = 719; 74.9%), with those considering themselves to
be Asian/Asian British constituting 15.6% of responses
received (n = 150). Most respondents had no personal
experience of CRC screening, but 98 individuals (10.2%)
had been screened in the past for CRC with one or
more of the four available CRC screening modalities
(FOBt, flexible sigmoidoscopy, colonoscopy or double
contrast barium enema). Just over a quarter of respon-
dents had some form of medical school affiliation
(n = 259; 27.0%). In terms of GP practice attributes,
GPs from mid-sized practices constituted the majority
of respondents: 51.6% (n = 495) worked in practices
with between two and four GPs, and a further 249
respondents (25.9%) were from practices with between
Table 1 Calculation of ‘attitude’ score for each respondent as a proxy measure of attitudes to FOBt screening
Survey question Score assigned for each response*§
1 2 3
How effective do you believe FOBt is in reducing cancer mortality in average risk patients
aged 50 years and older?
Not effective Somewhat
effective
Very effective
How often do you recommend FOBt for your asymptomatic average-risk patients of the
appropriate age?
Rarely/Never Sometimes Almost
always
How appropriate do you think FOBt is for population-based colorectal cancer screening? Not at all
appropriate
Somewhat
appropriate
Very
appropriate
* ‘Don’t know’ answers and missing values for each of these survey questions were interpolated using a mean score of the responder’s answers to the other
question(s)
§Total ‘attitude’ scores were calculated for each respondent. These were then dichotomised before further analysis with a score of seven or greater indicating a
positive attitude, and a score of six or less a negative attitude
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five and seven GPs. Most respondents were partners or
principals in their practice (87.1%; n = 836). Those in
single handed practices comprised 7.1% of responses
received (n = 68). Responses were split fairly evenly on
the basis of deprivation quartile and practice list size
(Table 3).
Attitudes towards cancer screening
Established national cancer screening programmes were
considered by the majority of respondents to be effective
in reducing mortality in average-risk patients, with 95.1%
of GPs (n = 893) perceiving cervical cancer screening to
be either ‘very’ or ‘somewhat’ effective, and 96.7%
(n = 908) believing the same of mammography. This
compared with 77.7% of respondents (n = 729) who con-
sidered FOBt as similarly effective. FOBt was recom-
mended to patients by GPs far less frequently than either
cervical smears or mammography: only 11% of respon-
dents (n = 105) stated that they recommended FOBt
‘almost always’ when appropriate for asymptomatic aver-
age-risk patients, compared with 96.5% (n = 926) recom-
mending cervical screening and 87.2% (n = 837) who
routinely endorse mammography.
Attitudes towards colorectal cancer screening
Respondents were asked whether they considered each
of the four principal CRC screening modalities to be
‘very’, ‘somewhat’, or ‘not at all’ appropriate for popula-
tion based CRC screening. Despite colorectal cancer
screening typically being recommended less frequently
than other cancer screening tests, FOBt was considered
by the majority of survey respondents to be an appropri-
ate test. FOBt was considered ‘very appropriate’ by
50.1% of GPs (n = 481), compared with 11.8% (n = 113)
believing the same of flexible sigmoidoscopy; 12.8%
(n = 123) endorsing colonoscopy, and only 3.1%
(n = 27) perceiving the double contrast barium enema
to be a ‘very appropriate’ screening test (Table 4).
FOBt was considered an inappropriate screening test
by 8.2% of GPs (n = 79), compared with 42.2%
(n = 405) agreeing that flexible sigmoidoscopy was inap-
propriate; 56.9% (n = 546) believing the same of colono-
scopy, and 76.2% (n = 665) finding double contrast
barium enema ‘not at all appropriate’.
Of those who responded to the question, 31.4% of GPs
(n = 72) agreed with the current recommended starting
age for FOBt screening (60 years old). 148 GPs (64.6%)
recommended beginning screening at a younger age,
with only 3.9% of those responding (n = 9) believing
that screening should begin at a later age than 60. The
majority of respondents advocated less frequent testing
than is currently recommended by the NHSBCSP. Of
those who responded, 22.5% (n = 43) agreed with the
current recommendation of biennial screening. 13.1%
(n = 25) believed that people should be screened more
frequently, and 64.4% (n = 123) advocated less frequent
screening. The preferred option was screening every
three years (37.2%; n = 71). There was little consistency
in the reporting of a recommended stopping age for
CRC screening in the asymptomatic average-risk
population.
Factors influencing recommendation of CRC screening
Respondents were asked about the factors which influ-
ence whether or not they typically recommend CRC
screening to their asymptomatic average-risk patients.
Most influential were evidence published in the medical
literature (569 GPs citing this as ‘very’ influential;
62.6%), and national policy relating to screening
Figure 1 Consort diagram detailing surveys mailed and returned.
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(n = 541; 63.6%). Amongst the least influential factors
were screening uptake rates, with only 18.8% of
GPs considering these to be very influential (n = 165),
(Table 5).
Perceived barriers to colorectal cancer screening
Respondents were asked about a series of patient and
system related barriers to CRC screening, indicating
whether they considered each to be a major, minor, or
insignificant barrier. GP responses are shown in Table 6.
Both patient and system related barriers were seen by
GPs as being influential, to varying degrees. Amongst
patient related barriers, a lack of patient awareness was
cited most frequently as a major obstacle to screening
uptake, with 599 respondents (64.8%) believing this to
be the case. Similarly important was perceived patient
embarrassment and anxiety (n = 465; 49.9%). The
patient barriers seen as the least problematic were a
lack of patient belief in the screening effectiveness, and
patient belief that colorectal cancer does not constitute
a serious threat to health (n = 262; 28.3% and n = 246;
26.7% respectively).
All four of the system related barriers outlined in the
survey were considered as major obstacles to CRC
screening by around half of those who responded. In
particular, the lack of trained healthcare providers to
conduct screening, and the shortage of healthcare provi-
ders trained adequately to investigate positive FOB tests
(n = 521; 57.8% and n = 492; 55.2% respectively). Analy-
sis of respondent characteristics did not show any statis-
tically significant differences between groups, according
to socio-demographic or practice attributes, suggesting
that the barriers to colorectal cancer screening were
perceived as similarly influential regardless of the char-
acteristics of individual GPs who responded.
Table 2 Practice characteristics of survey responders vs. non-responders
Characteristic Responders (%) Non-responders (%) All (%) Significance
Randomisation/stratification group
Small/Deprived 217 (22.6) 572 (26.4) 789 (25.3) X2 = 5.5
p = 0.141Small/Affluent 253 (26.4) 531 (24.5) 784 (25.1)
Large/Deprived 240 (25.0) 531 (24.5) 771 (24.7)
Large/Affluent 250 (26.0) 529 (24.5) 779 (24.9)
IMD quartile
Quartile 1 (least deprived) 227 (23.6) 463 (21.4) 690 (22.1) X2 = 10.3
p = 0.016Quartile 2 276 (28.8) 597 (27.6) 873 (28.0)
Quartile 3 234 (24.4) 483 (22.3) 717 (23.0)
Quartile 4 (most deprived) 223 (23.2) 620 (28.7) 843 (27.0)
GP count
Single handed 68 (7.1) 243 (11.2) 311 (10.0) X2 = 16.2
p = 0.0032 to 4 GPs 495 (51.6) 1,056 (48.8) 1,551 (49.7)
5 to 7 GPs 249 (25.9) 524 (24.2) 773 (24.8)
8 to 10 GPs 115 (12.0) 239 (11.0) 354 (11.3)
11 or more GPs 33 (3.4) 101 (4.7) 134 (4.3)
White British %
Less than 20 1 (0.1) 18 (0.8) 19 (0.6) X2 = 14.1
p = 0.00720 to 39 29 (3.0) 89 (4.1) 118 (3.8)
40 to 59 55 (5.7) 174 (8.1) 229 (7.3)
60 to 79 106 (11.0) 229 (10.6) 335 (10.7)
80 to 100 769 (80.1) 1,651 (76.4) 2,420 (77.5)
Not known 0 (0.0) 2 (0.1) 2 (0.1)
Practice setting
Hamlet 5 (0.5) 12 (0.5) 17 (0.6) X2 = 12.5
p = 0.131Village 62 (6.4) 96 (4.3) 157 (5.0)
Town and fringe 142 (14.8) 306 (13.7) 436 (14.0)
Urban 751 (78.2) 1,814 (81.3) 2,510 (80.4)
Not known 0 (0.0) 3 (0.1) 3 (0.1)
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Table 3 Mean FOBt attitude scores, and OR indicating association between practice and socio-demographic
characteristics of respondents with positive attitudes towards FOBt
Characteristic Number of respondents (%) * Mean FOBt attitude score § Bivariate OR (95% CI) Significance
Practice Attributes
Practice list size
Less than 3,800 200 (20.8) 6.0 1.1 (0.7 to 1.6) p = 0.792
3,800 to 5,499 187 (19.5) 5.9 0.9 (0.6 to 1.4) p = 0.742
5,500 to 7,999 215 (22.4) 5.9 0.9 (0.6 to 1.3) p = 0.525
8,000 to 10,889 177 (18.4) 5.9 1.0 (0.6 to 1.5) p = 0.940
10,890 or more 178 (18.5) 5.9 Reference
% of practice patients over 50
Less than 25 96 (10.0) 6.3 Reference
25 to 49 530 (55.2) 5.9 0.7 (0.5 to 1.1) p = 0.118
50 to 74 245 (25.5) 5.9 0.6 (0.4 to 1.0) p = 0.053
75 to 100 3 (0.3) 6.0 0.7 (0.1 to 8.0) p = 0.774
Practice IMD quartile
Quartile 1 (least deprived) 227 (23.6) 5.9 0.7 (0.5 to 1.1) p = 0.107
Quartile 2 276 (28.8) 5.8 0.6 (0.4 to 0.9) p = 0.012
Quartile 3 234 (24.3) 5.9 0.7 (0.5 to 0.9) p = 0.032
Quartile 4 (most deprived) 223 (23.2) 6.1 Reference
Practice GP count
Single handed 68 (7.1) 6.2 1.3 (0.5 to 3.0) p = 0.603
2 to 4 GPs 495 (51.6) 6.0 0.9 (0.4 to 1.8) p = 0.733
5 to 7 GPs 249 (25.9) 5.8 0.7 (0.3 to 1.5) p = 0.354
8 to 10 GPs 115 (12.0) 5.9 0.9 (0.4 to 2.0) p = 0.794
11 or more GPs 33 (3.4) 6.0 Reference
Socio-demographic characteristics
Ethnic group
White British 719 (74.9) 5.9 Reference
Asian/Asian British 150 (15.6) 6.3 1.9 (1.3 to 2.7) p = 0.001
Other 88 (9.2) 5.9 1.3 (0.8 to 2.0) p = 0.334
Medical school affiliation
Yes 259 (27.0) 6.0 1.3 (1.0 to 1.8) p = 0.094
No 621 (64.7) 5.9 Reference
Personal experience of CRC screening
Yes 98 (10.2) 6.4 1.6 (1.1 to 2.4) p = 0.044
No 836 (87.1) 5.9 Reference
All respondents 960 (100.0) 5.9
* Percentages may not total 100 due to missing responses
§Minimum possible score = 3; maximum = 9: for calculation of Odds Ratios, scores were dichotomised, (scores of 6 or lower indicative of a negative attitude; 7
or higher showing a positive attitude). Reported OR indicate association between socio-demographic/practice characteristics and positive attitudes towards faecal
occult blood testing
Table 4 Respondents’ perceived appropriateness of CRC screening tests for population based CRC screening
Faecal Occult Blood Test (%) Flexible Sigmoidoscopy (%) Colonoscopy (%) Double Contrast Barium Enema (%)
Very appropriate 481 (50.1) 113 (11.8) 123 (12.8) 27 (3.1)
Somewhat appropriate 382 (39.8) 403 (42.0) 255 (26.6) 181 (20.7)
Not at all appropriate 79 (8.2) 405 (42.2) 546 (56.9) 665 (76.2)
Missing responses 18 (1.9) 39 (4.1) 36 (3.8) 87 (9.1)
Total (%) 960 (100.0) 960 (100.0) 960 (100.0) 960 (100.0)
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Attitudes towards screening delivery
Respondents were in general strongly in favour of popu-
lation-based CRC screening being organised centrally, as
is the case in the NHSBCSP, rather than delivered
directly by GPs, with 78.7% (n = 755) agreeing that cen-
trally organised screening was appropriate. Similarly,
despite a recognition by the majority of respondents
that CRC screening could be effectively performed by
trained nurse practitioners (77.5%; n = 744), 62.1% of
GPs (n = 596) believed that CRC screening could be
effectively performed by patients themselves, using
home testing kits.
Attitudes towards FOBt
Respondent attitudes towards FOBt were assessed
through the calculation of an attitude score. The mean
score for all respondents (n = 960) was 5.9. Only 43
respondents (4.5%) scored the maximum of nine (indi-
cating a very positive attitude), and 6.8% (n = 65) scored
the minimum of three (very negative attitude). Mean
scores were calculated according to both practice attri-
butes and socio-demographic characteristics of respon-
dents, and remained very similar across all groups and
sub-groups (Table 3). Binary logistic regression was
used to calculate bivariate Odds Ratios evaluating the
association of socio-demographic and practice attributes
with FOBt attitude scores. No significant associations
were found between FOBt attitude and practice list size;
percentage of registered patients aged over 50; the num-
ber of GPs working in a practice, or whether or not a
respondent indicated an affiliation with a medical
school, although those with such an affiliation (n = 259;
27.0%) were more likely to have a positive attitude
towards FOBt than those without (bivariate OR: 1.3;
CI 1.0 to 1.8).
Personal experience of CRC screening was found to be
significantly associated with a positive attitude towards
FOBt, with respondents who had undergone CRC screen-
ing in the past (regardless of modality) more likely to
have a positive attitude than those who had not (bivariate
OR: 1.6; CI 1.1 to 2.4). Similarly, respondent ethnicity
was found to have a significant association with a positive
attitude towards FOBt. Those considering themselves
Asian/Asian British were more likely than White British
respondents to have a positive attitude (bivariate OR: 1.9;
CI 1.3 to 2.7). A significant association was also found
between practice deprivation quartile and FOBt attitude.
Survey respondents from less deprived quartiles were less
likely to have a positive attitude towards CRC screening
with FOBt than those from the most deprived quartile -
those in quartile two were nearly half as likely as those in
quartile four to accept FOBt as beneficial (bivariate OR:
0.6; CI 0.4 to 0.9).
It might be expected that survey respondents from
non-White British ethnic groups may be disproportio-
nately concentrated in socio-economically deprived
areas. However, even after controlling for the possible
confounding influence of practice deprivation quartile
on FOBt attitude by ethnic group, the significance of
the observed associations remained, although they were
Table 5 Factors influencing GP recommendation of CRC screening
Factor Very influential (%) Somewhat influential (%) Not influential (%) Total (%)
Clinical evidence in medical literature 569 (62.6) 306 (33.7) 34 (3.7) 909 (94.7)
Screening uptake rates 165 (18.8) 456 (51.9) 257 (29.3) 878 (91.5)
Continuing education/conferences/meetings 320 (35.6) 492 (54.7) 88 (9.8) 900 (93.8)
Primary Care Trust (PCT) policy 367 (40.7) 412 (45.7) 123 (13.6) 902 (94.0)
National policy 541 (63.6) 266 (31.3) 43 (5.1) 850 (88.5)
Table 6 Perceived barriers to colorectal cancer screening
Barrier Not a barrier (%) Minor barrier (%) Major barrier (%) Total (%)
Patient related
Patient fear of finding cancer 97 (10.4) 612 (65.6) 224 (24.0) 933 (97.2)
Patient believes screening ineffective 262 (28.3) 489 (52.8) 175 (18.9) 926 (96.5)
Patient embarrassment/anxiety 57 (6.1) 410 (44.0) 465 (49.9) 932 (97.1)
Patient unaware of screening 57 (6.1) 268 (29.0) 599 (64.8) 924 (96.3)
Patient does not perceive CRC as a serious threat 246 (26.7) 437 (47.5) 237 (25.8) 920 (95.8)
System related
Screening costs too much 116 (12.7) 355 (38.8) 444 (48.5) 915 (95.3)
GPs do not actively recommend screening 145 (15.8) 403 (44.0) 367 (40.1) 915 (95.3)
Shortage of trained providers to conduct screening 67 (7.4) 314 (34.8) 521 (57.8) 902 (94.0)
Shortage of trained providers to investigate positive FOBt 88 (9.9) 311 (34.9) 492 (55.2) 891 (92.8)
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less pronounced (multivariate OR for ethnic group: 1.8;
CI 1.2 to 2.6; p = 0.002; multivariate OR for deprivation
quartile two: 0.7; CI 0.5 to 0.9; p = 0.039).
Discussion
Despite the recent establishment of the NHS Bowel
Cancer Screening Programme, and the consequently
limited direct engagement of primary care in adminis-
tering screening for colorectal cancer, there will inevita-
bly be ongoing demands on GPs to provide information
and advice about CRC screening. These demands are
likely to come from both patients within the age range
covered by the NHSBCSP, due to the national advertis-
ing of the programme, and from those outside of the
target age groups, prompted by commercial companies
focusing on these populations [27]. Research has found
that GPs can influence their patients in the decision to
have CRC screening [28,29], and that GP recommenda-
tions can be particularly influential in prompting long
term screening compliance [30]. Therefore, the positive
engagement of GPs with CRC screening (and with FOBt
in particular), is required if screening uptake rates are to
reach acceptable levels, and the projected CRC mortality
reductions observed in randomised controlled trials of
FOBt screening are to be achieved in practice [30].
The findings from this survey raise a number of issues.
CRC screening in general, and FOBt in particular, are typi-
cally perceived as less effective in their potential to reduce
mortality amongst the appropriate target age groups than
better established cancer screening tests such as cervical
smears and mammography. This has important conse-
quences for GP engagement with CRC screening (and for
the uptake of population-based screening), as research has
found the perceived efficacy of different screening options
to be a clear determinant of clinical practice [21,22],
despite comparable evidence of effectiveness from rando-
mised controlled trials [31]. A number of patient and sys-
tem-related barriers to screening uptake were also
identified by respondents. However, the majority of GPs
supported centrally organised delivery of CRC screening,
as well as believing that population-based screening could
be effectively performed by patients using home testing
kits. This broad endorsement of the screening approach
followed in the NHSBCSP suggests that GPs are largely
supportive of the manner in which the programme is
delivered, which may contribute positively to their likeli-
hood of recommending FOBt to their patients.
Nevertheless, the factors affecting GP attitudes
towards, and recommendation of, FOBt remain unclear.
In line with other research evidence, we found few
socio-demographic or GP practice attributes to be statis-
tically significant determinants of attitudes towards CRC
screening [22-24]. The inability of GP practice attributes
in particular to account for observed attitudes suggests
that we may need to consider the role of other, cross-
cutting psychosocial, cultural or educational factors in
explaining GP attitudes towards FOBt and their poten-
tial role in facilitating patient uptake of CRC screening.
These cross-cutting factors may not be easily reducible
to pre-defined demographic and associated characteris-
tics. It may be the case that the greatest potential gains
in increasing uptake of population-based CRC screening
lie in better understanding and addressing patient-
related factors in addition to those relating to healthcare
professionals [32,33].
Finally, this survey found that GPs in non-White eth-
nic groups were more likely to have a positive attitude
towards FOBt screening, and were consequently more
likely to recommend it to their patients than those in
the White British ethnic group. This runs counter to
evidence (although much of it US based), that healthcare
professionals belonging to certain ethnic minority
groups are less likely to recommend bowel cancer
screening to their patients, particularly where their
patients are from similar ethnic backgrounds. This asso-
ciation was noted in work on screening uptake rates in
the UK colorectal cancer screening pilot [14]. Here,
CRC screening uptake rates were lower for individuals
registered with an Asian GP, especially when the GP
was of the Muslim faith. Uptake rates were similarly
found to be lower for patients registered with single
handed GP practices, and in those located in more
deprived areas [34]. Our findings in relation to the asso-
ciations between ethnicity and deprivation in determin-
ing GP attitudes to CRC screening using FOBt may be
evidence of a disjuncture between attitudes, subsequent
GP behaviour, and crucially, patient compliance with
CRC screening which needs to be explored further
through both qualitative and quantitative research.
Limitations
There were some limitations to this study. First, the sur-
vey asked GPs about their attitudes towards CRC
screening using FOBt and whether or not they typically
recommend it to their patients. As previously discussed,
we do not know if the stated attitudes conform to actual
clinical practice, although respondents were assured of
the confidentiality of their responses, thereby minimis-
ing the likelihood of false reporting. Nevertheless, in the
absence of tangible measurements of GP practice, the
degree to which attitudes translate into behaviours and
the mechanisms by which this may occur remains
unclear. Similarly, despite research evidence that GP
recommendations can have beneficial impacts on patient
compliance with CRC cancer screening, we do not know
the extent to which the attitudes and perceptions
expressed by our respondents have such effects on
patient uptake of screening in this context. There is a
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clear need for research which undertakes assessment of
GP attitudes alongside investigation into actual patient
uptake of CRC screening.
A further limitation is the non-response bias observed
with regard to the socio-demographic and GP practice
attributes of survey respondents and non-respondents.
With respondents from less deprived areas over-repre-
sented in the sample in comparison to those from more
deprived locations, the observed association between
deprivation and GP attitudes towards FOBt screening
may be overstated. This may also have had an effect on
the association seen between GP ethnic group and FOBt
attitudes, since deprivation and ethnicity are known to
be closely correlated. The findings outlined here must
therefore be interpreted with caution.
Finally, the survey response rate (30.7%; n = 960) was
relatively low in comparison to other postal surveys of
healthcare professionals [35,36]. The reasons for this are
unknown, but it is possible that only GPs motivated by, or
interested in CRC screening responded to the survey, and
that the observed positive attitudes towards FOBt outlined
in the current study are over-represented. Nevertheless,
the number of survey responses received constitutes a lar-
ger sample size than other surveys of GP attitudes towards
CRC screening [21,22,28]. Many of these studies were con-
ducted internationally, in healthcare settings different from
that of the UK, whereas the current research reports find-
ings directly relevant to the UK context.
Conclusions
Colorectal cancer screening presents significant chal-
lenges for primary care, and further evidence is needed
about the ways in which the delivery and uptake of
screening programmes can be improved. The success of
population-based screening for CRC will be determined
to a large extent by GP attitudes, beliefs and support,
particularly with regard to faecal occult blood testing.
Previous research has implied that South Asian GPs are
more likely to have negative attitudes towards FOBt.
However, our research suggests that this is not a group
that requires targeted interventions in order to increase
their support for the NHSBCSP. Of the available
CRC screening tests, GPs perceived FOBt to be the most
appropriate for population-based screening. Nevertheless,
only 50.1% of GPs reported finding this test ‘very appro-
priate’, and a number of patient and system-related bar-
riers to screening uptake were identified by respondents.
Additional file 1: Survey instrument. Survey instrument used to collect
data on GP attitudes and practices regarding faecal occult blood testing
for colorectal cancer.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2296-11-
20-S1.DOC ]
Authors’ contributions
Survey data collection and analysis was carried out by SC. The first draft of
this article was composed by SD, and was revised critically by all authors. All
authors have read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 22 August 2009
Accepted: 9 March 2010 Published: 9 March 2010
References
1. Atkin WS: Impending or pending? The national bowel cancer screening
programme. BMJ 2006, 332:742.
2. Macaffee D, Gemmil E, Lund J: Colorectal cancer: current care, future
innovations and economic considerations. Expert Rev Pharmacoeconomics
Outcomes Res 2006, 6:195-206.
3. Coleman M, Cooper N, Ellis L, Rachet B, Rasulo D, Shah A, Westlake S: One
and five year relative survival for patients diagnosed in 1998-2004 in
‘Spearhead’ PCTs compared with those in the rest of England: 10
common cancers by sex. London: National Office of Statistics 2008.
4. Office of National Statistics: Mortality statistics: review of the Registrar
General on deaths by cause, sex and age in England and Wales. London:
Office of National Statistics 2003, 2(29).
5. Berrino F, De Angelis R, Sant M, Rosso S, Lasota M, Coebergh J,
Santaquilani M: Survival for eight major cancers and all cancers
combined for European adults diagnosed in 1995-99: results of the
EUROCARE-4 study. Lancet Oncology 2007, 8(9):773-783.
6. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E: Screening for
colorectal cancer using the faecal occult blood test, Hemoccult.
Cochrane Database Syst Rev 2007, , 1: CD001216.
7. Towler B, Irwig L, Glasziou P, Weller D, Kewenter J: Screening for colorectal
cancer using the faecal occult blood test, hemoccult. Cochrane Database
Syst Rev 1998, 3.
8. Barrett J, Jiwa M, Rose P, Hamilton W: Pathways to the diagnosis of
colorectal cancer: an observational study in three UK cities. Fam Pract
2006, 23(1):15-19.
9. NHS Bowel Cancer Screening Programme: NHS Cancer Screening
Programmes. 2008http://www.cancerscreening.nhs.uk/bowel.
10. Parkin M: Charity predicts 20,000 fewer deaths from bowel cancer.
2007http://info.cancerresearchuk.org/news/archive/pressreleases/2007/july/
342588.
11. Weller D, Moss S, Butler P, Campbell C, Coleman D, Melia J, Robertson R:
English Pilot of Bowel Cancer Screening: an evaluation of the second
round. Final Report to the Department of Health. Institute of Cancer
Research 2006.
12. Weller D, Coleman D, Robertson R, Butler P, Melia J, Campbell C, Parker R,
Patnick J, Moss S: The UK colorectal cancer screening pilot: results of the
second round of screening in England. Br J Cancer 2007, 97:1601-1605.
13. Alexander F, Weller D: Evaluation of the UK colorectal cancer screening
pilot: final report. 2003.
14. Szczepura A, Johnson M, Orbell S, Gumber A, O’Sullivan I, Clay D, Owen D:
Ethnicity: UK Colorectal Cancer Screening Pilot: Final Report. 2003.
15. Vernon SW: Participation in colorectal cancer screening: a review. J Natl
Cancer Inst 1997, 89(19):1406-1422.
16. Ferreira M, Dolan NC, Fitzgibbon ML, Davis TC, Gorby N, Ladewski L, Liu D,
Rademaker AW, Medio F, Schmitt BP, Bennett CL: Health care provider-
directed intervention to increase colorectal cancer screening among
veterans: results of a randomized controlled trial. J Clin Oncol 2005,
23:1548-1554.
17. Federici A, Rossi P, Bartolozzi F, Farchi S, Borgia P, Guastcchi G: The role of
GPs in increasing compliance to colorectal cancer screening: a
randomised controlled trial. Cancer Causes Control 2006, 17(1):45-52.
18. Thompson RS, Michnich ME, Gray J, Friedlander L, Gilson B: Maximizing
compliance with hemoccult screening for colon cancer in clinical
practice. Med Care 1986, 24(10):904-14.
19. Myers RE, Sifri R, Hyslop T, Rosenthal M, Vernon SW, Cocroft J, Wolf T,
Andrel J, Wender R: A randomized controlled trial of the impact of
Damery et al. BMC Family Practice 2010, 11:20
http://www.biomedcentral.com/1471-2296/11/20
Page 9 of 10
targeted and tailored interventions on colorectal cancer screening.
Cancer 2007, 1(110):2083-91.
20. Klabunde CN, Lanier D, Breslau ES, Zapka JG, Fletcher RH, Ransohoff DF,
Winawer SJ: Improving colorectal cancer screening in primary care
practice: innovative strategies and future directions. J Gen Intern Med
2007, 22:1195-205.
21. Turner GB, Chin MW, Foster NM, Emery J, Forbes GM: Attitudes of Western
Australian general practitioners to colorectal cancer screening. Medical
Journal of Australia 2006, 185(4):237.
22. Tong RJ, Clarke VA: Colorectal cancer: A survey of community beliefs and
behaviours in Victoria. Medical Journal of Australia 1998, 169(1):37-40.
23. Subramanian S, Klosterman M, Amonkar MM, Hunt TL: Adherence with
colorectal cancer screening guidelines: a review. Prev Med 2004,
38:536-550.
24. Klabunde CN, Frame PS, Meadow A, Jones E, Nadel M, Vernon SW: A
national survey of primary care physicians’ colorectal cancer screening
recommendations and practices. Preventive Medicine 2003, 36:352-362.
25. Index of Multiple Deprivation. 2004http://www.communities.gov.uk/
archived/general-content/communities/indicesofdeprivation/216309/.
26. Nadel MR, Shapiro JA, Klabunde CN, Seeff LC, Uhler R, Smith RA,
Ransohoff DF: A national survey of primary care physicians’ methods for
screening for fecal occult blood. Annals of Internal Medicine 2005,
142(2):86-94.
27. National Independent Bowel Cancer Screening Programme. http://www.
pocl.co.uk.
28. Salkeld GP, Solomon MJ, Short L, Ward J: Measuring the importance of
attributes that influence consumer attitudes to colorectal cancer
screening. ANZ Journal of Surgery 2003, 73:128-132.
29. Thomas RJ, Clarke VA: Colorectal cancer: A survey of community beliefs
and behaviours in Victoria. Medical Journal of Australia 1998, 169(1):37-40.
30. Zarychanski R, Chen Y, Bernstein CN, Herbert PC: Frequency of colorectal
cancer screening and the impact of family physicians on screening
behaviour. CMAJ 2007, 177(6):593-597.
31. Young J, Ward J, Sladden M: Do the beliefs of Australian GPs about the
effectiveness of cancer screening accord with the evidence?. Journal of
Medical Screening 1998, 5:67-68.
32. Cole SR, Young GP, Byrne D: Participation in screening for colorectal
cancer based on a faecal occult blood test is improved by endorsement
by the primary care practitioner. Journal of Medical Screening 2002,
9:147-152.
33. Jepson R, Weller D, Alexander F, Walker J: Impact of UK colorectal cancer
screening pilot on primary care. British Journal of General Practice 2005,
January:20-25.
34. Szczepura A, Price C, Gumber A: Breast and bowel cancer screening
uptake patterns over 15 years for UK South Asian ethnic minority
populations, corrected for differences in socio-demographic
characteristics. BMC Public Health 2008, 8:346.
35. Stokes-Lampard HJ, Wilson S, Allan T, Waddell C, Kehoe S: Vaginal vault
smears - ‘know more - do less’: a questionnaire survey of primary
healthcare practitioners. Cytopathology 2005, 16:244-251.
36. Wilson S, Parle J, Roberts L, Roalfe A, Hobbs R, Clark P, Sheppard M,
Gammage M, Pattison H, Franklyn J: Prevalence of subclinical thyroid
dysfunction in the elderly in England - the Birmingham Elderly Thyroid
Study (BETS): a community based cross-sectional survey. J Clin Endocrinol
Metab 2006, 91(12):4809-4816.
Pre-publication history
The pre-publication history for this paper can be accessed here:http://www.
biomedcentral.com/1471-2296/11/20/prepub
doi:10.1186/1471-2296-11-20
Cite this article as: Damery et al.: Colorectal cancer screening using the
faecal occult blood test (FOBt): a survey of GP attitudes and practices in
the UK. BMC Family Practice 2010 11:20.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Damery et al. BMC Family Practice 2010, 11:20
http://www.biomedcentral.com/1471-2296/11/20
Page 10 of 10
